Skip to main content
Senores Pharmaceuticals IPO
50.78xsubscribed

Senores Pharmaceuticals IPO

Pharmaceuticals & Drugs
listed
₹14,136Min. investment

Senores Pharmaceuticals Limited IPO Details

SectorPharmaceuticals & Drugs
Price range₹372 – ₹391
IPO type
Regular
Lot size38 shares
Issue size₹582Cr
Red Herring Prospectus
Read
RevenueApr 2023 - Mar 2024
₹214.52CrLower than sector avg
Growth rate3Y CAGR
289%

Senores Pharmaceuticals IPO Subscription Status

Date
QIB
NII
Retail
Total
24-Dec-24
58.86 times (X)
46.32 times (X)
34.27 times (X)
50.78 times (X)

As on 24-Dec-24, 4:30 PM

Senores Pharmaceuticals IPO Timeline

  1. Pre-apply
    19 Dec 2024
  2. Bid start
    20 Dec 2024
  3. Bid end
    24 Dec 2024
  4. Allotment
    26 Dec 2024
  5. Release of funds
    27 Dec 2024
  6. Demat transfer
    27 Dec 2024
  7. Listing
    30 Dec 2024

About Senores Pharmaceuticals Limited

Senores Pharmaceuticals Limited, established in 2017, is a research-driven company focused on developing and manufacturing a wide range of generic pharmaceutical products. The company operates through two key business models: Marketed products (ANDA products and sourced products) and contract development and manufacturing operations (CDMO). As of September 2024, Senores Pharmaceuticals has received approvals for 19 ANDA (Abbreviated New Drug Application) and has commercialised 21 products from these ANDA approvals. Some of the company’s products also have exclusivity periods in key markets, during which no other company can launch competing versions of the same product for six months.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Senores IPO

New manufacturing facility
The company will invest ₹107 crore in Havix for a sterile injection facility in Atlanta.
Repayment of loans
The company will use ₹73.48 crore for loan repayment and ₹20.22 crore for Havix's loan repayment.
Working capital requirements
The company will allocate ₹43.26 crore for its working capital and ₹59.48 crore to subsidiaries.

Compare

CompanyRevenue*3Y growthPATP/E ratioD/E ratio
This IPO₹214.52Cr289%₹32.71Cr32.021.07
This sector (avg.)₹1,331.47Cr0%₹193.4Cr60.870.43
₹52,578.44Cr---₹10,980.1Cr36.980.03
₹9,360Cr---₹2,191Cr64.600
₹11,516.09Cr---₹1,911.25Cr62.640.42

*Revenue for financial year 2023-24. Lower P/E and D/E ratios are generally preferred.

Senores Pharmaceuticals IPO Contact Details

Company NameSenores Pharmaceuticals Limited

How to apply for Senores Pharmaceuticals IPO?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Senores IPO FAQs